You are here: Home » Markets » News
UltraTech Cement nears record high on healthy demand outlook
Business Standard
Web Exclusive

Growth, value stocks are largely pricing in vaccine hope, says UBS

The vaccine may induce a serious frontloading of the rally before logistical challenges or slower growth normalisation begins to bother markets, says UBS

Topics
Coronavirus Vaccine | Global Markets | UBS

Puneet Wadhwa  |  New Delhi 



The vaccine may induce a serious frontloading of the rally before logistical challenges or slower growth normalisation begins to bother markets
The vaccine may induce a serious frontloading of the rally before logistical challenges or slower growth normalisation begins to bother markets

Global growth and value stocks are pricing in the development of a vaccine to combat the Covid-19 pandemic, says a November 10 note by .

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, November 11 2020. 12:45 IST

RECOMMENDED FOR YOU

.